Abstract PS12-05: First Efficacy Results of a 2-Stage Simon’s Design Randomised Phase 2 of Darolutamide or Capecitabine in Patients with Triple-Negative, Androgen Receptor Positive Advanced Breast Cancer (UCBG06-3)
Cancer Research（2021）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined